CBS: Questions remain about COVID-19 booster shots
UC's Dr. Trisha Wise-Draper recommends third dose of mRNA vaccines to boost antibody production
While federal officials continue to analyze the need for the general public to receive a third dose of the currently available mRNA COVID-19 vaccines, certain immunocompromised groups are already eligible for a booster shot.
Dr. Trisha Wise-Draper, medical director of the UC Cancer Center's Clinical Trial Office and UC associate professor of medicine in the Division of Hematology/Oncology, said research has shown cancer patients in particular should receive a third dose as soon as possible.
"Certain cancer patients, especially those with blood disorders, are more at risk of not developing antibodies to the vaccine and remain vulnerable to the infection,” Wise-Draper told Local 12 News, in a story that was picked up nationally by news affiliates. "[Many patients] are at exceedingly high risk of serious disease and mortality from COVID-19."
Watch the full Local 12 report.
Featured photo at top: Shutterstock.com
Related Stories
Design World: Medical applications of 3-D printing
August 18, 2022
Design World featured the University of Cincinnati's Frank Rybicki in an article about different ways CAD and 3-D printing have helped advance medical care.
UC research examines barriers to treatment of COVID-19 in local...
August 18, 2022
New research from the University of Cincinnati,examines the barriers as well as those that are helpful in the prevention and treatment of COVID-19 in Latinx families in Cincinnati. Researchers identified primary barriers that include insecurities in food, jobs and housing and immigration. Key facilitators included having trusted messengers of health-related information.
UC to help supply semiconductor workforce
August 17, 2022
The University of Cincinnati will help supply the workforce needed to make the Midwest a leader in semiconductor and microelectronics, media outlets including Spectrum News and WVXU reported.